- Home
- SENEB vs KBDC Comparison
SENEB vs KBDC Comparison
Compare SENEB & KBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SENEB | KBDC |
|---|---|---|
| Founded | 1949 | 2021 |
| Country | United States | United States |
| Employees | 6895 | N/A |
| Industry | Packaged Foods | |
| Sector | Consumer Staples | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 880.5M | 918.9M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | SENEB | KBDC |
|---|---|---|
| Price | $138.75 | $14.74 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $15.50 |
| AVG Volume (30 Days) | 468.0 | ★ 267.8K |
| Earning Date | 06-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 13.16% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $193.84 |
| Revenue Next Year | N/A | $9.00 |
| P/E Ratio | ★ $12.93 | $34.49 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $90.19 | $13.06 |
| 52 Week High | $164.98 | $16.40 |
Technical Indicators
Market Signals| Indicator | SENEB | KBDC |
|---|---|---|
| Relative Strength Index (RSI) | 54.94 | 51.78 |
| Support Level | $131.45 | $14.02 |
| Resistance Level | $164.98 | $15.02 |
| Average True Range (ATR) | 0.63 | 0.39 |
| MACD | -1.45 | -0.04 |
| Stochastic Oscillator | 21.77 | 31.67 |
Price Performance
Historical ComparisonAbout SENEB Seneca Foods Corp. Class B
Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.
About KBDC Kayne Anderson BDC Inc.
Kayne Anderson BDC Inc is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company, investing mainly in first-lien senior secured loans, with a secondary focus on unitranche and split-lien loans to middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation mainly through debt investments in middle-market companies.